OP
OWP PHARMACEUTICALS, INC.
SEC filingPharmaceuticals · Lisle, IL
Amount raised$2.4Msold at filing
Total offering$2.4M
Investors in the raise19count reported to the SEC
FiledSep 9, 2025first sale Jul 25, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
TROY HAMMONDDirector
STEVE BOURNEExecutive Officer
MATT LITFINDirector
KURT FLORIANDirector
SCOTT BOYERExecutive Officer, Director
BRUCE DUNCANDirector
Executive officers, directors and promoters as listed on the Form D.